Many infections with these superbug strains were very recently treatable with mainline antibiotics. They’re now becoming fatal as antibiotics fail one by one.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.
The company is now just another aggregator in the budget hotel sector. And the shift does make sense; OYO wants to cut losses and its India business isn’t all that important anymore.
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.